CRVS
Corvus Pharmaceuticals Inc
Halal Rating :
Last Price
$5.02
Last updated:
Market Cap
-
7D Change
-3.46%
1 Year Change
144.88%
Company Overview
Industries
Exchange
Next Earnings Date
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing precision medicine therapies for patients with cancer and other immune-mediated diseases. The company's main focus is on developing novel immunotherapy approaches that target specific immune cells and signaling pathways.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Corvus Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.